ADX vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a low P/E of 7.72 and a current price ($23.69) below the Graham Number ($40.16), the company exhibits alarming earnings deterioration, negative earnings growth, and a dangerously high payout ratio of 109.18%, raising sustainability concerns. Profitability margins are anomalously high—particularly the 981.24% profit margin and 100% gross margin—likely reflecting non-operational or one-time gains rather than sustainable business performance. The technical trend score of 10/100 signals strong bearish momentum, and lack of analyst coverage further limits confidence in forward visibility.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ADX vs JPM: Head-to-Head Comparison
This page compares Adams Diversified Equity Fund, Inc. (ADX) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.